HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer.

AbstractBACKGROUND:
Thromboxane synthase (TXS) metabolizes prostaglandin H2 into thromboxanes, which are biologically active on cancer cells. TXS over-expression has been reported in a range of cancers, and associated with angiogenesis and poor outcome. TXS has been identified as a potential therapeutic target in NSCLC. This study examines a link between TXS expression, angiogenesis, and survival in NSCLC.
METHODS:
TXS and VEGF metabolite levels were measured in NSCLC serum samples (n=46) by EIA. TXB2 levels were correlated with VEGF. A 204-patient TMA was stained for TXS, VEGF, and CD-31 expression. Expression was correlated with a range of clinical parameters, including overall survival. TXS expression was correlated with VEGF and CD-31. Stable TXS clones were generated and the effect of overexpression on tumor growth and angiogenesis markers was examined in-vitro and in-vivo (xenograft mouse model).
RESULTS:
Serum TXB2 levels were correlated with VEGF (p<0.05). TXS and VEGF were expressed to a varying degree in NSCLC tissue. TXS was associated with VEGF (p<0.0001) and microvessel density (CD-31; p<0.05). TXS and VEGF expression levels were higher in adenocarcinoma (p<0.0001) and female patients (p<0.05). Stable overexpression of TXS increased VEGF secretion in-vitro. While no significant association with patient survival was observed for either TXS or VEGF in our patient cohort, TXS overexpression significantly (p<0.05) increased tumor growth in-vivo. TXS overexpression was also associated with higher levels of VEGF, microvessel density, and reduced apoptosis in xenograft tumors.
CONCLUSION:
TXS promotes tumor growth in-vivo in NSCLC, an effect which is at least partly mediated through increased tumor angiogenesis.
AuthorsMary Clare Cathcart, Kathy Gately, Robert Cummins, Clive Drakeford, Elaine W Kay, Kenneth J O'Byrne, Graham P Pidgeon
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1842 Issue 5 Pg. 747-55 (May 2014) ISSN: 0006-3002 [Print] Netherlands
PMID24480048 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Vascular Endothelial Growth Factor A
  • Thromboxane B2
  • Thromboxane-A Synthase
Topics
  • Carcinoma, Non-Small-Cell Lung (blood supply, enzymology, metabolism)
  • Humans
  • Lung Neoplasms (blood supply, enzymology, metabolism)
  • Neovascularization, Pathologic
  • Thromboxane B2 (metabolism)
  • Thromboxane-A Synthase (metabolism)
  • Tissue Array Analysis
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: